Company intelligence / Profile preview
Abela Pharmaceuticals
Lake Forest, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Abela Pharmaceuticals, Inc. is a private pharmaceutical company founded in 2005 and based in Lake Forest, California. The company has focused on developing small molecule therapeutics for neurological injuries, specifically severe head trauma/craniocerebral trauma. Its lead asset ("AbelaDrug200") reached Phase 1/2 clinical trials to assess safety and preliminary efficacy in patients with closed severe head injury; the trial's current status is unknown as of June 2025. Patent filings suggest expertise in dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations for infectious diseases and other indications.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Abela Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abela Pharmaceuticals.